Bioventus Inc. 10-Q

Financial Statements (unaudited)

Item 1. Financial Information—Notes to the Unaudited Consolidated Condensed Financial Statements—Note 11. Commitments and Contingencies of this Quarterly Report on Form 10-Q . Information Regarding Cash Flows Cash and cash equivalents as of June 27, 2026 totaled $29.5 million, compared to $51.2 million as of December 31, 2025. The change in cash was primarily due to the following: Six Months Ended Change (in thousands, except for percentage) June 27, 2026 June 28, 2025 $ % Net cash from operating activities $ 28,807 $ 6,607 $ 22,200 NM Net cash from investing activities (3,034) (2,195) (839) 38.2 % Net cash from financing activities (46,576) (13,716) (32,860) 239.6 % Effect of exchange rate changes on cash (978) 632 (1,610) NM Net change in cash, cash equivalents $ (21,781) $ (8,672) $ (13,109) 151.2 % Operating Activities Net cash inflows from operating activities increased by $22.2 million compared to the prior year period, primarily reflecting lower interest payments due to reduced debt levels and favorable interest rates, as well as decreases in inventory purchases and bonus payments, partially offset with higher compensation-related costs. Investing Activities Net cash outflows from investing activities increased by $0.8 million compared to the prior year period, primarily as a result of purchases of investments, partially offset by lower capital expenditures. Capital expenditures in both periods primarily consisted of information technology-related investments. Financing Activities Net cash outflows from financing activities was $46.6 million for the six months ended June 27, 2026, primarily reflecting $42.0 million of discretionary prepayments of long-term debt. Net cash outflows from financing activities was $13.7 million for the six months ended June 28, 2025, primarily reflecting a $19.8 million payment of contingent consideration related to a prior acquisition, partially offset by $5.0 million of net borrowings under our former revolving credit facility. Off-balance Sheet Arrangements We do not have any off-balance sheet arrangements. Contractual Obligations There have been no material changes to our contractual obligations as disclosed in our 2025 10-K. Critical Accounting Estimates Our discussion of operating results is based upon the unaudited consolidated condensed financial statements and accompanying notes, which have been prepared in accord